Lacosamida Stada (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, which stabilizes hyperexcitable neuronal membranes and reduces the repetitive firing of neurons that can trigger seizure activity.

The appropriate dose is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal and hepatic function, seizure type, and response to therapy. No fixed regimen is provided here.

The pregnancy category for lacosamide is not definitively established. Use during pregnancy or lactation should only occur when the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many agents that block fast inactivation. This can offer complementary seizure control when combined with other antiepileptics, and it may have a distinct side‑effect profile compared with drugs such as carbamazepine or levetiracetam.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, heat and direct light, and ensure the container is tightly closed to maintain stability.

Lacosamida Stada is taken orally, usually as a tablet. It should be swallowed whole with water and can be taken with or without food, following the dosing schedule prescribed by the treating physician.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, the potential for suicidal thoughts or behavior, severe skin reactions like Stevens‑Johnson syndrome, hypersensitivity reactions, and significant liver enzyme elevations.

Patients with known hypersensitivity to lacosamide or any excipients, those with severe cardiac conduction disorders, and individuals for whom the prescriber determines the risk outweighs the benefit should avoid using this medication.